Langer et al. reply [2]

Trends in Pharmacological Sciences

Volumn 19, Issue 4, 1998, Pages 128-130

  Langer, Salomon Z ^a   Scatton, B ^a   Schoemaker, H ^a   Rein, W ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; AUTORECEPTOR; MIRTAZAPINE; PRESYNAPTIC RECEPTOR; RECEPTOR SUBTYPE;

DEPRESSION; DRUG RECEPTOR BINDING; HUMAN; LETTER; NEUROTRANSMITTER RELEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

EID: 0032055213     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(98)01183-3     Document Type: Article

References (46)

1. Laduron P. M. Trends Pharmacol. Sci. 16:1995;338-343.
2. Levin B. E. Brain Res. 321:1984;180-182.
3. Levin B. E., Biegon A. Brain Res. 311:1984;39-50.
4. Levin B. E. Brain Res. 321:1984;180-182.
5. Wamsley J. K. Mol. Neurobiol. 6:1992;313-321.
6. Broaddus W. C., Bennette J. P. Brain Res. 52:1990;273-277.
7. Van-der-Kooy D., Weinreich P., Nagy J. I. Neuroscience. 19:1986;139-146.
8. Langer S. Z. Trends Pharmacol. Sci. 18:1997;95-99.
9. Cragg S. J., Greenfield S. A. J. Neurosci. 17:1997;5738-5746.
10. Coggan J. S., Paysan J., Conroy W. G., Berg D.K. J. Neurosci. 17:1997;5798-5806.
11. Pineyro G., Castanon N., Hen R., Blier P. NeuroReport. 7:1995;353-359.
12. Dubocovich M. L., Langer S. Z. J. Physiol. 237:1974;505-519.
13. Farah M. B., Langer S. Z. Br. J. Pharmacol. 52:1974;549-557.
14. Langer S. Z., Adler-Grachinsky E., Giorgi O. Nature. 265:1977;648-650.
15. Enero M. A., Langer S. Z., Rothlin R. P., Stefano F. J. E. Br. J. Pharmacol. 44:1972;672-688.
16. Curet O., Dennis T., Scatton B. J. Pharmacol. Exp. Ther. 240:1987;327-336.
17. Haggendal, J. (1970) in New Aspects of Storage and Release Mechanisms of Catecholamines (Schumann, H.J. and Kroneberg, G., eds), pp. 100-109, Springer-Verlag.
18. Hedqvist P. Acta Physiol. Scand. 75:1969;511-512.
19. Dubocovich M. L., Langer S. Z. J. Physiol. 251:1975;737-762.
20. Schoemaker H. et al. J. Pharmacol. Exp. Ther. 280:1997;83-97.
21. Perrault G., Depoortere R., Morel E., Sanger D. J., Scatton B. J. Pharmacol. Exp. Ther. 280:1997;73-82.
22. Bristow L. J. et al. Trends Pharmacol. Sci. 18:1997;185-188.
23. Loo H. et al. Br. J. Psychiatry. 170:1997;18-22.
24. Coukell A. J., Spencer C. M., Benfield P. CNS Drugs. 6:1996;237-256.
25. Martinot J. L. et al. Psychopharmacology. 124:1996;154-158.
26. Moller H. J. et al. Psychopharmacology. 132:1997;396-401.
27. Freeman H. L. Int. Clin. Psychopharmacology. 12:1997;S11-S17.
28. Carpenter W. R., Heinrichs D. W., Wagman A. M. I. Am. J. Psychiatry. 145:1988;578-583.
29. Moller H. J. et al. Psychopharmacology. 115:1994;221-228.
30. Carpenter W. T. et al. Am. J. Psychiatry. 152:1995;827-838.
31. Meltzer H. Y. Am. J. Psychiatry. 152:1995;821-825.
32. Haddjeri N., Blier B., de Montigny C. J. Pharmacol. Exp. Ther. 277:1996;861-871.
33. de Boer T., Nefkens F., van Helvoirt A., van Delft A. M. J. Pharmacol. Exp. Ther. 277:1996;852-860.
34. Tulen J. H. M. et al. J. Clin. Psychopharmacol. 16:1996;135-145.
35. Marrila M. et al. Eur. J. Neuropsychopharmacol. 5:1995;441-446.
36. Loffelholz K., Muscholl E. Naunyn-Schmiedeberg's Arch. Pharmacol. 265:1969;1-15.
37. Raiteri M., Maura G., Versace P. J. Pharmacol. Exp. Ther. 224:1983;679-684.
38. Pittaluga A., Raiteri M. Eur. J. Pharmacol. 191:1990;231-234.
39. Bonanno G., Gemignani A., Fedele E., Fontana G., Raiteri M. J. Pharmacol. Exp. Ther. 259:1991;1153-1159.
40. Maura G., Raiteri M. Eur. J. Pharmacol. 129:1986;333-337.
41. Arvieu L. et al. NeuroReport. 7:1996;1973-1976.
42. El-Mansari M., Blier P. Br. J. Pharmacol. 118:1996;681-689.
43. Maura G. et al. J. Neurochem. 60:1993;1179-1182.
44. Wilkinson L. O. et al. Neuropharmacology. 32:1993;205-208.
45. O'Connor J. J., Kruk Z. L. Br. J. Pharmacol. 106:1992;524-532.
46. Sleight A. J., Cervenka A., Peroutka S. J. Neuropharmacology. 29:1990;511-513.